In a filing, Relay Therapeutics Inc revealed its President, R&D Bergstrom Donald A unloaded Company’s shares for reported $2800.0 on Mar 27 ’25. In the deal valued at $2.84 per share,986 shares were sold. As a result of this transaction, Bergstrom Donald A now holds 615,052 shares worth roughly $1.8 million.
Then, Rahmer Peter sold 247 shares, generating $701 in total proceeds. Upon selling the shares at $2.84, the insider now owns 402,184 shares.
Before that, Catinazzo Thomas sold 4,864 shares. Relay Therapeutics Inc shares valued at $13,814 were divested by the Chief Financial Officer at a price of $2.84 per share. As a result of the transaction, Catinazzo Thomas now holds 374,567 shares, worth roughly $1.1 million.
Wells Fargo initiated its Relay Therapeutics Inc [RLAY] rating to an Equal weight in a research note published on April 17, 2025; the price target was $4. A number of analysts have revised their coverage, including Jefferies’s analysts, who increased its forecast for the stock in early September from “a Hold” to “a Buy”. Oppenheimer revised its rating on September 10, 2024. It rated RLAY as “a Perform” which previously was an “an Outperform”.
Price Performance Review of RLAY
On Tuesday, Relay Therapeutics Inc [NASDAQ:RLAY] saw its stock jump 6.55% to $2.93. Over the last five days, the stock has gained 14.01%. Relay Therapeutics Inc shares have fallen nearly -28.88% since the year began. Nevertheless, the stocks have fallen -52.05% over the past one year. While a 52-week high of $10.72 was reached on 01/10/25, a 52-week low of $1.77 was recorded on 04/07/25. SMA at 50 days reached $3.16, while 200 days put it at $5.39.
Levels Of Support And Resistance For RLAY Stock
The 24-hour chart illustrates a support level at 2.78, which if violated will result in even more drops to 2.64. On the upside, there is a resistance level at 3.01. A further resistance level may holdings at 3.10. The Relative Strength Index (RSI) on the 14-day chart is 54.10, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.36, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 1.69%. Stochastics %K at 93.67% indicates the stock is a selling.
How much short interest is there in Relay Therapeutics Inc?
A steep rise in short interest was recorded in Relay Therapeutics Inc stocks on 2025-03-31, growing by 1.87 million shares to a total of 18.06 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-28 was 16.19 million shares. There was a rise of 10.36%, which implies that there is a positive sentiment for the stock.
